Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as galcanezumab in participants with episodic migraine.
Epistemonikos ID: 0f17584018a4f1c20eac49379286fc045baf25c3
First added on: May 12, 2024